Correspondence |

Localized Contact Urticaria Caused by Lidocaine/Tetracaine Peel

Jennifer Channual, BS; Jashin J. Wu, MD; Christopher B. Zachary, MBBS, FRCP
Arch Dermatol. 2009;145(4):499-500. doi:10.1001/archdermatol.2009.56.
Text Size: A A A
Published online


The lidocaine, 7%/tetracaine, 7%, cream Pliaglis (Galderma Laboratories, Fort Worth, Texas) (hereinafter, “LT peel”) is a novel topical anesthetic cream that forms a self-occlusive, pliable membrane on exposure to air. The LT peel has been shown to be a safe and effective form of local anesthesia for various dermatologic procedures.1 Minimal adverse effects associated with the LT peel have been reported, limited primarily to transient skin erythema with or without skin discoloration or edema.1 Herein, we report a case of contact urticaria and discuss possible causes of such allergic manifestations and potential hazards and precautions recommended with the use of the LT peel.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1.

Slightly edematous, well-demarcated, erythematous plaque appearing 15 minutes after application of lidocaine, 7%/tetracaine, 7%, cream to the face. Arrows designate the margins of the plaque and correspond to the edges of the area where the cream was applied.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Well-demarcated areas of facial erythema and mild lip edema without evidence of lingual edema.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

Mild lip edema occurred 15 minutes after lidocaine, 7%/tetracaine, 7%, cream was applied to the face (A) and resolved, as did the contact urticaria, within 30 minutes of treatment with a single 50-mg oral dose of diphenhydramine (B).

Graphic Jump Location




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles